Edition:
United Kingdom

Sunesis Pharmaceuticals Inc (SNSS.OQ)

SNSS.OQ on NASDAQ Stock Exchange Capital Market

3.44USD
11 Dec 2017
Change (% chg)

-- (--)
Prev Close
$3.44
Open
--
Day's High
--
Day's Low
--
Volume
--
Avg. Vol
29,371
52-wk High
$4.44
52-wk Low
$1.84

Select another date:

Mon, Dec 4 2017

BRIEF-Sunesis Pharmaceuticals Inc - Daniel Swisher Resigns As CEO Effective End Of 2017

* SUNESIS PHARMACEUTICALS INC - DANIEL SWISHER RESIGNS AS CEO EFFECTIVE END OF 2017

BRIEF-Sunesis Pharmaceuticals Appoints William Quinn As CFO

* SUNESIS PHARMACEUTICALS APPOINTS WILLIAM QUINN AS CHIEF FINANCIAL OFFICER AND SENIOR VICE PRESIDENT, FINANCE AND CORPORATE DEVELOPMENT

BRIEF-RA Capital Management reports 10.4 pct passive stake in Sunesis Pharmaceuticals as of Oct 25

* RA Capital Management reports 10.4 percent passive stake in Sunesis Pharmaceuticals as of October 25 – SEC Filing‍​ Source text: [http://bit.ly/2yZzSQ5] Further company coverage:

BRIEF-Sunesis Pharmaceuticals Inc Q3 loss per share ‍$0.43​

* Sunesis Pharmaceuticals reports third quarter 2017 financial results and recent highlights

BRIEF-Sunesis announces pricing of $20 million offering of securities

* Sunesis announces pricing of $20 million offering of securities

BRIEF-Sunesis Pharmaceuticals announces proposed public offering of common stock, preferred stock and warrants

* Sunesis announces proposed public offering of common stock, preferred stock and warrants

BRIEF-Sunesis Pharmaceuticals reports second quarter results

* Sunesis Pharmaceuticals reports second quarter 2017 financial results and recent highlights

BRIEF-Balyasny Asset Management reports 9.32 pct passive stake in Sunesis Pharmaceuticals

* Balyasny Asset Management reports a 9.32 percent passive stake in Sunesis Pharmaceuticals Inc as of June 23, 2017 - SEC filing Source text: (http://bit.ly/2tRWgIv) Further company coverage:

BRIEF-Sunesis Pharmaceuticals amends loan agreement

* Sunesis Pharmaceuticals Inc - on June 30, 2017, co entered into an amendment, or amendment, to loan and security agreement dated march 31, 2016

Select another date: